Postmarketing Commitments

Following approval of a drug or biologic product, the U.S. Food and Drug Administration (FDA) may request and/or require the sponsoring company to conduct further studies that are designed to gather additional information about the product's safety, effectiveness, and/or optimal use. These Postmarketing Commitment (PMC) studies build upon the data that was submitted for approval.

To view AbbVie's U.S. Postmarketing Commitments (and, those of the prior sponsor, Abbott Laboratories), click here.

The PMC Summary Table includes our active Postmarketing Commitments and provides the following information, organized alphabetically by product name:

  • Name of Product

  • NDA/BLA Number

  • Description of Commitment

  • Date Commitment Given

  • Projected Completion Date

  • Commitment Status

Please note that the status and/or number of AbbVie's Postmarketing Commitments shown on the FDA website may differ from the information displayed on our PMC Summary Table because of the timing of content review and website updates. The status categories used in the PMC Summary Table are consistent with categories used by the FDA.

Information about AbbVie's PMCs will be updated twice a year, to reflect new commitments as well as the progress we have made in fulfilling our existing postmarketing commitments. Once the FDA determines a PMC is fulfilled or should not be completed, or if AbbVie terminates a study before completion date, those PMCs will be removed from our PMC Summary Table.

The PMCs listed in the PMC Summary Table include nonclinical (nonhuman), clinical (medical), and epidemiological studies that AbbVie has agreed to conduct to gather additional information about the safe and effective use of our approved products. This website does not contain technical chemistry, manufacturing and controls PMCs, or PMCs for products for which AbbVie does not hold the U.S. regulatory approval.

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

EXIT ABBVIE.COM

The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.

As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to continue to this product-specific site?

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?